Annual Operating Profit
-$77.51 M
-$4.86 M-6.69%
31 December 2021
Summary:
Concert Pharmaceuticals annual operaing income is currently -$77.51 million, with the most recent change of -$4.86 million (-6.69%) on 31 December 2021. During the last 3 years, it has fallen by -$4.86 million (-6.69%).CNCE Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$29.61 M
-$3.92 M-15.27%
30 September 2022
Summary:
Concert Pharmaceuticals quarterly operating income is currently -$29.61 million, with the most recent change of -$3.92 million (-15.27%) on 30 September 2022.CNCE Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$124.27 M
-$2.81 M-2.31%
30 September 2022
Summary:
Concert Pharmaceuticals TTM operating income is currently -$124.27 million, with the most recent change of -$2.81 million (-2.31%) on 30 September 2022.CNCE TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNCE Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -6.7% | -10.5% | -88.1% |
| 5 y5 years | -39.4% | -62.3% | -59.1% |
CNCE Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -183.7% | -122.5% | -221.5% |
Concert Pharmaceuticals Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$29.61 M(+15.3%) | -$124.27 M(+2.3%) |
| June 2022 | - | -$25.68 M(-28.7%) | -$121.46 M(+35.6%) |
| Mar 2022 | - | -$36.03 M(+9.3%) | -$89.56 M(+15.5%) |
| Dec 2021 | -$77.51 M(+6.7%) | -$32.95 M(+23.0%) | -$77.51 M(+17.3%) |
| Sept 2021 | - | -$26.80 M(-530.9%) | -$66.06 M(+12.7%) |
| June 2021 | - | $6.22 M(-125.9%) | -$58.63 M(-24.8%) |
| Mar 2021 | - | -$23.98 M(+11.5%) | -$77.98 M(+7.3%) |
| Dec 2020 | -$72.65 M(-8.1%) | -$21.50 M(+11.1%) | -$72.65 M(+0.8%) |
| Sept 2020 | - | -$19.36 M(+47.4%) | -$72.10 M(+1.6%) |
| June 2020 | - | -$13.13 M(-29.6%) | -$70.98 M(-8.1%) |
| Mar 2020 | - | -$18.65 M(-11.0%) | -$77.27 M(-2.2%) |
| Dec 2019 | -$79.02 M(+42.2%) | -$20.95 M(+14.9%) | -$79.02 M(+1.1%) |
| Sept 2019 | - | -$18.24 M(-6.1%) | -$78.13 M(+1.2%) |
| June 2019 | - | -$19.43 M(-4.8%) | -$77.22 M(+7.0%) |
| Mar 2019 | - | -$20.39 M(+1.6%) | -$72.17 M(+29.8%) |
| Dec 2018 | -$55.58 M(-160.0%) | -$20.06 M(+15.7%) | -$55.58 M(+15.2%) |
| Sept 2018 | - | -$17.34 M(+20.6%) | -$48.26 M(-147.8%) |
| June 2018 | - | -$14.37 M(+277.6%) | $100.92 M(-1.4%) |
| Mar 2018 | - | -$3.81 M(-70.1%) | $102.31 M(+10.4%) |
| Dec 2017 | $92.65 M | -$12.74 M(-109.7%) | $92.65 M(-0.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2017 | - | $131.83 M(-1115.9%) | $93.23 M(-286.2%) |
| June 2017 | - | -$12.98 M(-3.7%) | -$50.07 M(-1.2%) |
| Mar 2017 | - | -$13.47 M(+10.8%) | -$50.66 M(-1.0%) |
| Dec 2016 | -$51.17 M(-306.4%) | -$12.15 M(+6.0%) | -$51.17 M(+33.4%) |
| Sept 2016 | - | -$11.47 M(-15.5%) | -$38.35 M(+7.8%) |
| June 2016 | - | -$13.57 M(-2.9%) | -$35.58 M(-280.7%) |
| Mar 2016 | - | -$13.97 M(-2207.7%) | $19.68 M(-20.6%) |
| Dec 2015 | $24.79 M(-181.0%) | $663.00 K(-107.6%) | $24.79 M(+61.2%) |
| Sept 2015 | - | -$8.69 M(-120.9%) | $15.38 M(-6.6%) |
| June 2015 | - | $41.69 M(-570.0%) | $16.47 M(-150.0%) |
| Mar 2015 | - | -$8.87 M(+1.4%) | -$32.95 M(+7.7%) |
| Dec 2014 | -$30.60 M(+593.8%) | -$8.74 M(+14.9%) | -$30.60 M(+11.5%) |
| Sept 2014 | - | -$7.61 M(-1.5%) | -$27.43 M(+1.8%) |
| June 2014 | - | -$7.73 M(+18.5%) | -$26.94 M(+174.9%) |
| Mar 2014 | - | -$6.52 M(+16.8%) | -$9.80 M(+122.2%) |
| Dec 2013 | -$4.41 M(-76.3%) | -$5.58 M(-21.6%) | -$4.41 M(-27.3%) |
| Sept 2013 | - | -$7.12 M(-175.6%) | -$6.06 M(-675.8%) |
| June 2013 | - | $9.41 M(-933.2%) | $1.05 M(-112.6%) |
| Mar 2013 | - | -$1.13 M(-84.4%) | -$8.36 M(+15.6%) |
| Dec 2012 | -$18.61 M(+64.0%) | -$7.23 M | -$7.23 M |
| Dec 2011 | -$11.35 M | - | - |
FAQ
- What is Concert Pharmaceuticals annual operaing income?
- What is the all time high annual operating profit for Concert Pharmaceuticals?
- What is Concert Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for Concert Pharmaceuticals?
- What is Concert Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for Concert Pharmaceuticals?
What is Concert Pharmaceuticals annual operaing income?
The current annual operating profit of CNCE is -$77.51 M
What is the all time high annual operating profit for Concert Pharmaceuticals?
Concert Pharmaceuticals all-time high annual operaing income is $92.65 M
What is Concert Pharmaceuticals quarterly operating income?
The current quarterly operating profit of CNCE is -$29.61 M
What is the all time high quarterly operating profit for Concert Pharmaceuticals?
Concert Pharmaceuticals all-time high quarterly operating income is $131.83 M
What is Concert Pharmaceuticals TTM operating income?
The current TTM operating profit of CNCE is -$124.27 M
What is the all time high TTM operating profit for Concert Pharmaceuticals?
Concert Pharmaceuticals all-time high TTM operating income is $102.31 M